CleanTech Alliance Washington Annual Meeting

Share on Facebook
Share on Twitter
LinkedIn
Email
Reprints

Rocky Mountain Institute CEO Jules Kortenhorst headlines the third annual meeting of the CleanTech Alliance Washington. Members pay $75. Non-members pay $125. Prices increase after Nov. 5. Find more information here.

Interested in Seattle Events?

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
Xcelerating Life Sciences Boston: Special Report
Biopharma's Future in Digital Health

From Our Editors · Podcast
Xcelerating Life Sciences Boston: The Highlights Podcast
Learn what's fueling Boston's biotech and digital health investment and partnership opportunities

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Seattle

Bio Roundup: Blackstone's Billions, Biogen Finishes Filing, Novavax at "Warp Speed" & More

BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data

NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO

Alpine Immune Sciences Lands AbbVie as R&D Partner for Lupus Drug

Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA

New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech

This Week’s AI & Drug Discovery Conference Xcelerating Life Sciences San Francisco Features insitro, Atomwise, twoXAR, InterVenn, Engine Biosciences & More

Code for Cures: Life Sciences Thrives on San Francisco’s Software Heritage

Akili Interactive’s Video Game for ADHD Gets the FDA All Clear

Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes

The 2020 National Xconomy Awards

Xcelerating Life Sciences Seattle

Xcelerating Life Sciences New York

CleanTech Alliance Washington Annual Meeting

Share

Interested in Seattle Events?

Underwriters and Partners

Xcelerating Life Sciences Boston: Special Report

Xcelerating Life Sciences Boston: The Highlights Podcast

What’s Next in Neuroscience Therapies

Xconomy on Demand

We offer a number of ways to subscribe for free!